Transactions

Katzenell Dimant /

KD Represents FloLive in its $21.5M Series B Financing Round

Our firm represented floLive in its $21.5M Series B financing round, led by 83North, Dell Ventures, Saban Ventures and Qualcomm …

Read more
Katzenell Dimant /

KD Represents Track160 in its $5M seed financing led by ADvantage Sports Tech Fund

KD Represents Track160 in its $5M A financing led by Tech Fund, German Premier Football league and leading angel investors. …

Read more
Katzenell Dimant /

KD Represents Veego in its $5M seed financing led by Bosch Ventures, State of Mind Ventures and North First Ventures

KD Represents Veego in its $5M seed financing led by Bosch Ventures, State of Mind Ventures and North First Ventures. …

Read more
Katzenell Dimant /

KD represents SAManage in its sale to Solarwinds for US$ 350 million.

KD represented SAManage in its sale to Solarwinds for US$ 350 million. We’ve been representing SAManage since its incorporation, in …

Read more
Katzenell Dimant /

Ayalon joins TLV Medical in a strategic transaction

We’re extremely proud of our client, TLV Medical Center, for closing a strategic transaction with Ayalon insurance company. This transaction …

Read more
Katzenell Dimant /

KD represents eyeSight in a $15,000,000 financing round

KD represents eyeSight in a $15,000,000 financing round led by Jebsen, Golden Arie VC and others. Gideon Shmuel, congratulations. Read …

Read more
Katzenell Dimant /

KD represented Ella Deposits in a NIS 1,000,000,000 publicly traded structured bond financing

KD represented Ella Deposits in a NIS 1,000,000,000 publicly traded structured bond financing. For more information see publication in Globes.

Read more
Katzenell Dimant /

KD represents MaterialsZone in an investment by Sarona Ventures

KD represents MaterialsZone in an investment by Sarona Ventures for the development of a platform that will allow researchers to …

Read more
Katzenell Dimant /

KD represents Steadymed in its acquisition by United Therapeutics for up to $216 million

KD has represented Steadymed since its early phase as an incubator company, and throughout its listing in the NASDAQ, including …

Read more